RNA exon editing
Roche Partners with Ascidian in $1.8 Billion RNA Exon Editing Deal for Neurological Diseases
Roche, Ascidian, RNA exon editing, neurological diseases, partnership, therapeutics
Actionable Insights Powered by AI
Roche, Ascidian, RNA exon editing, neurological diseases, partnership, therapeutics